{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:00:03Z","timestamp":1788908403301,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There has been tremendous growth in regenerative medicine during the last decade. For erectile dysfunction (ED), after the inclusion of low-intensity shockwave therapy as a treatment modality for ED management by the European Association of Urology sexual health guidelines, intracavernosal injection of platelet-rich plasma (PRP) has gained popularity between urologists and patients as a novel ED therapeutic modality with initial promising results. However, limited clinical data exist regarding efficacy and safety in patients with ED. Furthermore, despite numerous preclinical studies in other tissues and organs, the mechanism of action for restoring erectile function remains undetermined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This systematic review aims to present the current status of preclinical and clinical evidence regarding the use of PRP as treatment option for ED.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic literature search was conducted using PubMed, Cochrane, and ScienceDirect databases, until February 2023 for studies exploring the effect of PRP on ED.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 517 articles, 23 of which were included in this review. These were 7 preclinical (of which 1 was a comparative trial and 6 were placebo-controlled randomized controlled trials) and 16 clinical studies (of which 1 was a comparative trial, 5 were randomized trials, and 2 were placebo-controlled randomized controlled trials). Preclinical data support the regenerative role of PRP in erectile tissue, in accordance with existing evidence in other tissues. Randomized clinical studies, as well as the first 2 available randomized, placebo-controlled clinical trials, showed promising efficacy and a lack of any adverse events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>As PRP for ED is widely used worldwide, there is an urgent need for high-quality studies with long-term follow-up. Standardization of research protocols, especially on the quality of PRP preparation, is also needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sxmrev\/qead027","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T03:27:36Z","timestamp":1690946856000},"page":"359-368","source":"Crossref","is-referenced-by-count":17,"title":["Platelet-rich plasma for the treatment of erectile dysfunction: a systematic review of preclinical and clinical studies"],"prefix":"10.1093","volume":"11","author":[{"given":"Evangelos","family":"Poulios","sequence":"first","affiliation":[{"name":"Aristotle University of Thessaloniki Department of Urology, G. Gennimatas Hospital, , Thessaloniki 54635 , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mykoniatis","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki Department of Urology, G. Gennimatas Hospital, , Thessaloniki 54635 , Greece"},{"name":"Institute for the Study of Urological Diseases , Thessaloniki 54622 , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pyrgidis","sequence":"additional","affiliation":[{"name":"Institute for the Study of Urological Diseases , Thessaloniki 54622 , Greece"},{"name":"University Hospital, LMU Munich Department of Urology, , Munich 81377 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kalyvianakis","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki Department of Urology, G. Gennimatas Hospital, , Thessaloniki 54635 , Greece"},{"name":"Institute for the Study of Urological Diseases , Thessaloniki 54622 , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Hatzichristou","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki Department of Urology, G. Gennimatas Hospital, , Thessaloniki 54635 , Greece"},{"name":"Institute for the Study of Urological Diseases , Thessaloniki 54622 , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"issue":"3","key":"2023112818371096000_ref1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive Health-2021 update: male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"2023112818371096000_ref2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.sxmr.2020.07.001","article-title":"Platelet-rich plasma and cellular therapies for sexual medicine and beyond","volume":"10","author":"Matz","year":"2022","journal-title":"Sex Med Rev"},{"issue":"8","key":"2023112818371096000_ref3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41443-021-00456-1","article-title":"The use of combination regenerative therapies for erectile dysfunction: rationale and current status","volume":"34","author":"Towe","year":"2021","journal-title":"Int J Impot Res"},{"issue":"4","key":"2023112818371096000_ref4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41443-021-00482-z","article-title":"The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation","volume":"34","author":"Israeli","year":"2021","journal-title":"Int J Impot Res"},{"issue":"1","key":"2023112818371096000_ref5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.sxmr.2020.03.005","article-title":"Novel treatments of erectile dysfunction: review of the current literature","volume":"9","author":"Raheem","year":"2021","journal-title":"Sex Med Rev"},{"issue":"2","key":"2023112818371096000_ref6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.sxmr.2018.12.006","article-title":"Platelet-rich plasma and treatment of erectile dysfunction: critical review of literature and global trends in platelet-rich plasma clinics","volume":"7","author":"Scott","year":"2019","journal-title":"Sex Med Rev"},{"issue":"12","key":"2023112818371096000_ref7","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/jsm.13051","article-title":"The new business of ED therapy","volume":"12","author":"Jenkins","year":"2015","journal-title":"J Sex Med"},{"issue":"3","key":"2023112818371096000_ref8","doi-asserted-by":"crossref","first-page":"100343","DOI":"10.1016\/j.esxm.2021.100343","article-title":"Restorative therapies for erectile dysfunction: position statement from the Sexual Medicine Society of North America (SMSNA)","volume":"9","author":"Liu","year":"2021","journal-title":"Sex Med"},{"issue":"7","key":"2023112818371096000_ref9","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"2","key":"2023112818371096000_ref10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/aja.2008.37","article-title":"The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model","volume":"11","author":"Ding","year":"2009","journal-title":"Asian J Androl"},{"issue":"11","key":"2023112818371096000_ref11","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/j.1743-6109.2012.02881.x","article-title":"The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model","volume":"9","author":"Wu","year":"2012","journal-title":"J Sex Med"},{"issue":"10","key":"2023112818371096000_ref12","doi-asserted-by":"crossref","first-page":"E294","DOI":"10.1002\/term.1806","article-title":"Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model","volume":"10","author":"Wu","year":"2013","journal-title":"J Tissue Eng Regen Med"},{"issue":"4S","key":"2023112818371096000_ref13","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/j.juro.2018.02.1408","article-title":"MP43-09 effects of platelet rich plasma on improving erectile dysfunction in streptozotocin-induced diabetic rats","volume":"199","author":"Liao","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"2023112818371096000_ref14","doi-asserted-by":"crossref","first-page":"100317","DOI":"10.1016\/j.esxm.2020.100317","article-title":"Intracavernous injection of autologous platelet-rich plasma ameliorates Hyperlipidemia-associated erectile dysfunction in a rat model","volume":"9","author":"Huang","year":"2021","journal-title":"Sex Med"},{"issue":"4","key":"2023112818371096000_ref15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jsxm.2020.12.016","article-title":"CXCL5 cytokine is a major factor in platelet-rich Plasma\u2019s preservation of erectile function in rats after bilateral cavernous nerve injury","volume":"18","author":"Wu","year":"2021","journal-title":"J Sex Med"},{"key":"2023112818371096000_ref16","author":"Wu"},{"issue":"4","key":"2023112818371096000_ref17","first-page":"76","article-title":"The effectiveness of intracavernous autologous platelet-rich plasma in the treatment of erectile dysfunction","author":"Chalyj","year":"2015","journal-title":"Urologiia"},{"issue":"1","key":"2023112818371096000_ref18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sxmr.2019.02.002","article-title":"Platelet-rich plasma therapy for male sexual dysfunction: myth or reality?","volume":"8","author":"Epifanova","year":"2019","journal-title":"Sex Med Rev"},{"issue":"1","key":"2023112818371096000_ref19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","article-title":"Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions","volume":"59","author":"Matz","year":"2018","journal-title":"Investig Clin Urol"},{"issue":"2 Suppl","key":"2023112818371096000_ref20","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.jsxm.2016.12.134","article-title":"146 The efficacy of platelet-rich plasma (PRP) as a supplemental therapy for the treatment of erectile dysfunction (ED): initial outcomes","volume":"14","author":"Banno","year":"2017","journal-title":"J Sex Med"},{"issue":"Suppl_3","key":"2023112818371096000_ref21","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.jsxm.2018.04.435","article-title":"529 treating erectile dysfunction with a combination of low-intensity shock waves (LISW) and platelet-rich plasma (PRP) injections","volume":"15","author":"Ruffo","year":"2018","journal-title":"J Sex Med"},{"issue":"1","key":"2023112818371096000_ref22","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.1016\/S1569-9056(19)31175-3","article-title":"Effectiveness and safety of platelet rich plasma (PrP) cavernosal injections plus external shock wave treatment for penile erectile dysfunction: first results from a prospective, randomized, controlled, interventional study","volume":"18","author":"Ruffo","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"2023112818371096000_ref23","first-page":"25","article-title":"Combined therapy for treating erectile dysfunction: first results on the use of low-intensity extracorporeal shock wave therapy and platelet-rich plasma","volume":"123","author":"Epifanova","year":"2019","journal-title":"BJU Int"},{"issue":"6","key":"2023112818371096000_ref24","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.jsxm.2020.04.120","article-title":"HP-3-1 platelet rich plasma and low-intensity pulsed ultrasound combination in erectile dysfunction treatment","volume":"17","author":"Zasieda","year":"2020","journal-title":"J Sex Med"},{"issue":"10","key":"2023112818371096000_ref25","doi-asserted-by":"crossref","first-page":"e14197","DOI":"10.1111\/and.14197","article-title":"Comparison of the efficacy of low-intensity shock wave therapy and its combination with platelet-rich plasma in patients with erectile dysfunction","volume":"53","author":"Geyik","year":"2021","journal-title":"Andrologia"},{"issue":"12","key":"2023112818371096000_ref26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.37506\/v10\/i12\/2019\/ijphrd\/192414","article-title":"Efficacy and safety of intracavernosal injection of autologous platelet rich plasma for treatment of erectile dysfunction","volume":"10","author":"Raaia","year":"2019","journal-title":"Indian J Public Health Res Dev"},{"issue":"5","key":"2023112818371096000_ref27","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jsxm.2019.03.228","article-title":"PO-01-091 Platelet rich plasma penile rejuvenation as a treatment for erectile dysfunction: an update","volume":"16","author":"Alkhayal","year":"2019","journal-title":"J Sex Med"},{"issue":"2","key":"2023112818371096000_ref28","doi-asserted-by":"crossref","first-page":"100313","DOI":"10.1016\/j.esxm.2020.100313","article-title":"Early clinical results of the tolerability, safety, and efficacy of autologous platelet-rich plasma administration in erectile dysfunction","volume":"9","author":"Ta\u015f","year":"2021","journal-title":"Sex Med"},{"issue":"9","key":"2023112818371096000_ref29","doi-asserted-by":"crossref","first-page":"e14162","DOI":"10.1111\/and.14162","article-title":"Smoking status and the baseline international index of erectile function score can predict satisfactory response to platelet-rich plasma in patients with erectile dysfunction: a prospective pilot study","volume":"53","author":"Zaghloul","year":"2021","journal-title":"Andrologia"},{"issue":"5","key":"2023112818371096000_ref30","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jsxm.2021.03.008","article-title":"Platelet-rich plasma (PRP) improves erectile function: a double-blind, randomized, placebo-controlled clinical trial","volume":"18","author":"Poulios","year":"2021","journal-title":"J Sex Med"},{"issue":"5","key":"2023112818371096000_ref31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","article-title":"Minimal clinically important differences in the erectile function domain of the international index of erectile function scale","volume":"60","author":"Rosen","year":"2011","journal-title":"Eur Urol"},{"key":"2023112818371096000_ref32","doi-asserted-by":"crossref","DOI":"10.1016\/j.purol.2022.05.002","article-title":"Pilot study of intra-cavernous injections of platelet-rich plasma (P-shot\u00ae) in the treatment of vascular erectile dysfunction","author":"Schirmann","year":"2022","journal-title":"Progres Urol"},{"issue":"6","key":"2023112818371096000_ref33","doi-asserted-by":"crossref","first-page":"e14421","DOI":"10.1111\/and.14421","article-title":"Assessment of the intracavernosal injection platelet-rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non-responding to on-demand oral PDE5 inhibitors","volume":"54","author":"Zaghloul","year":"2022","journal-title":"Andrologia"},{"issue":"1","key":"2023112818371096000_ref34","first-page":"120","article-title":"Platelet rich plasma in erectile dysfunction a double-blind, randomized, placebo-controlled clinical trial. Indian J forensic","volume":"17","author":"Khalef","year":"2023","journal-title":"Med Toxicol"},{"key":"2023112818371096000_ref35","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2023.01.028","article-title":"Is platelet rich plasma safe and effective in treatment of erectile dysfunction? Randomized controlled study","author":"Shaher","year":"2023","journal-title":"Urology"},{"issue":"2","key":"2023112818371096000_ref36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.sxmr.2020.12.004","article-title":"Platelet-rich plasma injections for erectile dysfunction and Peyronie\u2019s disease: a systematic review of evidence","volume":"10","author":"Alkandari","year":"2022","journal-title":"Sex Med Rev"},{"issue":"2","key":"2023112818371096000_ref37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10561-022-10039-z","article-title":"Platelet-rich plasma: a comparative and economical therapy for wound healing and tissue regeneration","volume":"24","author":"Verma","year":"2022","journal-title":"Cell Tissue Bank"},{"key":"2023112818371096000_ref38","doi-asserted-by":"crossref","first-page":"1029650","DOI":"10.3389\/fphys.2022.1029650","article-title":"Molecular pathogenesis and treatment of cavernous nerve injury-induced erectile dysfunction: a narrative review","volume":"13","author":"Song","year":"2022","journal-title":"Front Physiol"},{"issue":"2","key":"2023112818371096000_ref39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10047-014-0761-5","article-title":"Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems","volume":"17","author":"Kushida","year":"2014","journal-title":"J Artif Organs"},{"issue":"1","key":"2023112818371096000_ref40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsxm.2021.10.007","article-title":"The effect of combination treatment with low-intensity shockwave therapy and Tadalafil on mild and mild-to-moderate erectile dysfunction: a double-blind, randomized, placebo-controlled clinical trial","volume":"19","author":"Mykoniatis","year":"2022","journal-title":"J Sex Med"},{"issue":"2","key":"2023112818371096000_ref41","doi-asserted-by":"crossref","first-page":"e2036337","DOI":"10.1001\/jamanetworkopen.2020.36337","article-title":"Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis","volume":"4","author":"Mykoniatis","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/11\/4\/359\/53896097\/qead027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/11\/4\/359\/53896097\/qead027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T20:13:42Z","timestamp":1701202422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/11\/4\/359\/7234655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,1]]},"published-print":{"date-parts":[[2023,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qead027","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,8,1]]}}}